Tags : Sign

Sanofi and GSK Sign an Agreement with the UK Government

Shots: The two global companies will supply up to ~60M doses of a vaccine to the UK’s government to combat COVID-19 Sanofi leads the clinical development and registration of the vaccine and expects a P-I/II study to be initiated in Sept’2020, followed by a P-III study by the end of 2020. Additionally, the companies are […]Read More

Sanofi and MD Anderson Sign a Five-Year Pact to Expedite

Shots: Sanofi and MD Anderson collaborated for 5yrs. to ramp up the development of investigational treatments, including targeted and immune-therapies for oncology patients. The alliance will support investigations into additional indications and combinations for studies already in the clinic The collaboration will integrate MD Anderson’s clinical trials infrastructure and Sanofi’s pipeline of investigational treatments to […]Read More

GRYT Health and BMS Sign an Agreement to Launch Virtual

Shots: COVID Advocacy Exchange is a virtual platform targeted to unite patient advocacy organizations, patients, policy makers, healthcare practitioners and industry in the exchange of information and will also provide data, including weekly live interactive sessions to foster discussion and collaboration The platform will invite 100 global and local advocacy organizations and will provide access […]Read More

Gilead and Kite Sign a Three Years Agreement with oNKo-innate

Shots: oNKo-innate to receive an up front, clinical, regulatory & commercial milestones along with royalties on sales of immuno-oncology and cell therapy programs while in exchange, the company will utilize its genome-wide screening techniques and technology platform to discover novel immune cell targets enhancing NK cell anti-tumor immunity and to create NK cell therapies oNKo-innate […]Read More

The US FDA and FTC Sign Agreement to Support the

The partnership will address the false and misleading promotion about biosimilars within their respective authorities and prevent anti-competitive behavior. Additionally, the agencies will collaborate with participants from industry, academia and government agencies for discussing issues related to competition in the biologics market The agencies will collaboratively exchange the information for suitable practices in preventing the […]Read More

CRISPR Therapeutics and KSQ Therapeutics Cross Licenses their IP Rights

Shots: CRISPR to gain access to KSQ intellectual property (IP) for editing certain novel gene targets in its allogeneic oncology cell therapy programs while KSQ will get access to CRISPR’ IP for its autologous cell therapies including its existing eTIL cell franchise The agreement allows KSQ to leverage CRISPR’s editing technology in its eTIL programs, […]Read More

Bayer Signs a Clinical Collaboration Agreement with BMS and Ono

Shots: Bayer, BMS and Ono collaborate to evaluate the combination of Bayer’s Stivarga (regorafenib) with BMS & Ono’s Opdivo (nivolumab) vs regorafenib in patients with micro-satellite stable mCRC The collaboration follows safety data of regorafenib as 3L monothx. in P-III CORRECT study and the efficacy data of P-I REGONIVO study evaluating the combination of regorafenib […]Read More

Janssen(J&J) Signs an Exclusive Worldwide License Agreement with MeiraGTx for

Shots: Janssen to get exclusive WW license rights to develop & commercialize certain clinical candidates in MeiraGTx’s inherited retinal disease pipeline. Janssen also has an option to license the portfolio of products for gene targeting in inherited retinal disease, will be developed in collaboration with MeiraGTx The focus of the collaboration is to develop adeno-associated […]Read More

Domain Therapeutics Signs Research and License Agreement with Boehringer Ingelheim

Shots: Domain to receive upfront, milestones, and royalties on sales from Boehringer Ingelheim The focus of the agreement is to discover & develop GPCRs, using Domain’s DTect-All and bioSens-All technology to characterize compounds for Neuropsychiatric Diseases GPCRs are receptors present in CNS, activates by binding with stimulus or ligand and regulates the functions of brain […]Read More